Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Technology Journal.
Press releases published on August 13, 2025
Faster Guest Entry at Korea’s INSPIRE Entertainment Resort’s Casino, Powered by Regula’s Technology
GlobeNewswire
·
August 13, 2025
RESTON, Va., Aug. 13, 2025 (GLOBE NEWSWIRE) -- International guests arriving at South Korea’s largest foreigner-only casino, INSPIRE Entertainment Resort, now enjoy a significantly faster and more seamless check-in experience. Customer onboarding times …
UCLA, Rutgers, and Manhattan School of Music are Among the Winners of the Kaltura Digital Engagement Awards in Education 2025
GlobeNewswire
·
August 13, 2025
New York, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Kaltura (Nasdaq: KLTR), the AI Video Experience Cloud, has announced the winners of the 2025 Kaltura Digital Engagement Awards in Education. The awards were presented at the annual Kaltura Connect in Education …
Clinical Microbiology Market to Reach $6.9 Billion by 2029, Driven by Advanced Diagnostics and Regulatory Demand | MarketsandMarkets™.
GlobeNewswire
·
August 13, 2025
Delray Beach, FL, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Stringent quality standards, technological innovation, and global healthcare expansion accelerate market growth The global clinical microbiology market, valued at US$4.8 billion in 2023, stood at US$5.0 …
New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results
GlobeNewswire
·
August 13, 2025
SALT LAKE CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today released findings from its latest Cancer Risk Survey that uncover a striking contradiction in …
Clene to Present at the Emerging Growth Conference
GlobeNewswire
·
August 13, 2025
SALT LAKE CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment …
Center for Internet Security Selects Sophos as Premier Partner for Endpoint Security to Protect U.S. State and Local Government Organizations
GlobeNewswire
·
August 13, 2025
DALLAS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions for defeating cyberattacks, today announced it has been selected by the Center for Internet Security, Inc. (CIS) as the endpoint protection provider for …
LaunchDarkly Co‑Founder Edith Harbaugh Returns as Chief Executive Officer
GlobeNewswire
·
August 13, 2025
SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- LaunchDarkly, the comprehensive feature management platform, today announced that the company co‑founder and former CEO Edith Harbaugh has been named Chief Executive Officer, effective immediately. Harbaugh …
Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme
GlobeNewswire
·
August 13, 2025
First patient dosed with CUE-102 for recurrent glioblastoma multiforme (rGBM) at Dana-Farber Cancer Institute (DFCI) BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel …
Infinidat Wins 2025 FMS Award for Most Innovative AI Application with RAG Reference Architecture on the InfiniBox® G4 Platform
GlobeNewswire
·
August 13, 2025
WALTHAM, Mass., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that Infinidat’s Retrieval-Augmented Generation (RAG) reference architecture, operating on the new-generation InfiniBox® G4 …
Artelo Biosciences Provides Business Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
SOLANA BEACH, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, …
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
Topline results from the OV329 Phase 1 safety, tolerability and biomarker study remain on track for a readout in Q3 2025 $7.0 million royalty monetization agreement signed with Immedica Pharma AB for future ganaxolone royalties, delivering capital to the …
Fifth Annual PropTech Breakthrough Awards Program Releases List of 2025 Featured Winners
GlobeNewswire
·
August 13, 2025
LOS ANGELES, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PropTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes the world’s most innovative real estate technology companies and solutions, today announced the …
BioCardia and CART-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3D™ Fusion Imaging for Interventional Cardiology
GlobeNewswire
·
August 13, 2025
SUNNYVALE, Calif. and UTRECHT, Netherlands, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, and CART-Tech, B.V., a …
CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study
GlobeNewswire
·
August 13, 2025
- The CTMX-2051-101 study has enrolled 73 colorectal cancer patients to-date, aligned with the Company’s goal of providing a Phase 1 data update in Q1 2026 - - The CTMX-2051-101 study remains active and patients continue to be dosed with CX-2051 across all …
Bitdeer Announces July 2025 Production and Operations Update
GlobeNewswire
·
August 13, 2025
- Increased self-mining hashrate by 35% to 22.3 EH/s on continued deployment of SEALMINERs - 159 MW energized in Bhutan and Norway; Rockdale, Texas Hydro-cooling conversion completed SINGAPORE, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group ( …
BeyondSpring Reports Second‑Quarter 2025 Financial Results and Provides Corporate Update: Accelerates Momentum with Promising Clinical Advances and Strategic Leadership Appointment
GlobeNewswire
·
August 13, 2025
ASCO 2025 presentation: First-in-class agent Plinabulin drives immune re-sensitization in NSCLC patients progressed to PD-1/L1 therapies Med (Cell Press) Publication with MD Anderson Collaboration highlights Plinabulin’s rapid dendritic cell activation in …
MicroCloud Hologram Inc. Expects Net Profit for the First Half of 2025 to Exceed $33 Million
GlobeNewswire
·
August 13, 2025
SHENZHEN, China, Aug. 13, 2025 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, announced its preliminary financial results for the first half of 2025 . HOLO anticipates a significant …
FOXO TECHNOLOGIES INC. ANNOUNCES THAT ITS COMMON STOCK CAN BE QUOTED AND TRADED ON THE OVER THE COUNTER MARKET FROM AUGUST 13, 2025.
GlobeNewswire
·
August 13, 2025
WEST PALM BEACH, FLORIDA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (“FOXO” or the “Company”) announces that it has received a letter from NYSE on August 12, 2025 confirming that NYSE Regulation has determined to commence proceedings to …
BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer
GlobeNewswire
·
August 13, 2025
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies …
ElevateBio BaseCamp Achieves ICMC™ Certification for Commercial Cell and Gene Therapy Manufacturing Capabilities
GlobeNewswire
·
August 13, 2025
ICMC certification delivered by Dark Horse Consulting certifies ElevateBio’s compliant and scalable manufacturing capabilities for advanced therapies using U.S. and E.U. commercial-level evaluation standards BaseCamp is the first genetic medicine …